MASS PANIC over EBOLA in the CONGO as health care workers exposed and cases nearly double to 68 last week

Health authorities in the Democratic Republic of the Congo (DRC) have launched mass vaccinations in response to a rapidly escalating Ebola outbreak in Kasai province, where cases have more than doubled in just a week. The World Health Organization (WHO) confirmed that the Zaire ebolavirus, the most virulent strain of the disease, is responsible for the crisis. The outbreak, declared earlier this month, has already caused at least 16 deaths, including four healthcare workers, and prompted lockdowns in several communities.

• Health officials in the Democratic Republic of the Congo have launched mass vaccinations with the Ervebo shot in Kasai province, where Ebola cases surged from 28 to 68 in one week, leaving at least 16 dead.
• An initial 400 vaccine doses have been deployed in Bulape, with another 45,000 approved for release; antibody drug treatments like Ebanga (Mab114) are also being distributed to treatment centers.
• Residents in outbreak zones face lockdowns and travel checkpoints as local officials attempt to contain the spread of the deadly Zaire ebolavirus, which can kill up to 90% of patients without treatment.
• The outbreak, the DRC’s 16th since 1976, highlights Ebola’s ongoing threat, with WHO officials warning of parallels to past deadly epidemics, including the 2014–2016 West Africa crisis that killed over 11,000.

Mass Vaccinations Underway and Towns Locked Down as Panic Over Ebola Pandemic ‘Crisis’ Spreads

To contain the spread, the WHO has deployed an initial 400 doses of the Ervebo vaccine, an FDA-approved shot used only in outbreak situations. These first doses were dispatched to Bulape, currently the epicenter of the crisis, with more vaccines scheduled to arrive in the coming days. The WHO’s International Coordinating Group on Vaccine Provision has also authorized an additional 45,000 vaccines, significantly expanding the DRC’s stockpile beyond the 2,000 doses it already held.

Alongside vaccination efforts, treatment centers have received supplies of Mab114, branded as Ebanga, a monoclonal antibody therapy approved for Ebola. The drug blocks the viral glycoprotein that allows the Ebola virus to attach to host cells and replicate. Ebanga, along with another FDA-approved treatment called Inmazeb, has been shown to reduce mortality rates in patients.

Local officials describe the situation as a growing emergency. François Mingambengele, administrator of the Mweka territory that includes Bulape, called it “a crisis” as the number of infections continues to rise. Authorities have set up checkpoints around Kasai province to restrict travel and placed some residents under confinement in an effort to halt further transmission.

Ebola spreads through contact with blood, body fluids, or contaminated surfaces, and is often transmitted from infected animals such as bats or primates. The virus can cause severe disease with symptoms including fever, headache, diarrhea, vomiting, abdominal pain, and unexplained bleeding or bruising. Without treatment, Ebola’s mortality rate can reach 90 percent. The Zaire strain, now circulating in Kasai, typically kills between 36 and 90 percent of patients.

The current outbreak marks the DRC’s 16th recorded Ebola outbreak since the virus was first identified in 1976, and the seventh in Kasai province. Previous outbreaks in 2018 and 2020 in the country’s eastern regions each claimed over 1,000 lives. Globally, the deadliest outbreak occurred in West Africa between 2014 and 2016, with more than 28,600 cases reported and over 11,000 deaths. Could Bill Gates be behind this, like so many other disease outbreaks followed by mass-vaccination with toxic chemicals?

The first confirmed case in this outbreak was a pregnant woman admitted to Bulape General Reference Hospital on August 20 with a high fever, bloody stool, and weakness. She died within five days, and testing later confirmed Ebola infection.

The latest crisis in Congo follows a smaller outbreak earlier this year in Uganda, caused by the Sudan virus, which led to 12 confirmed cases and four deaths before being declared over in April. Meanwhile, concern over Ebola has reached beyond Africa. In February, two suspected cases in New York City were investigated after patients who had recently traveled from Uganda showed Ebola-like symptoms. Although the cases were not Ebola, the scare underscored the global vigilance required to track and contain the deadly virus.

As mass vaccinations roll out and towns lock down, global health officials remain on high alert, emphasizing that quick containment measures are critical to preventing another large-scale Ebola pandemic.

Bookmark plague.info to your favorite independent websites for updates on TWO HUNDRED new gain-of-function viruses NIH, CDC and WHO plan to release into the “wild” along with Ebola to start the next PLANDEMIC.

Sources for this article include:

Pandemic.news

GatewayPundit.com

NaturalNews.com

DailyMail.co.uk